Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, Large B-Cell, Diffuse × HBI-8000 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia 1 Colorectal Neoplasms 1

Interventions

Rituximab 231 Cyclophosphamide 218 Etoposide 101 Prednisone 91 Doxorubicin 90 Vincristine 88 Peripheral Blood Stem Cell Transplantation 80 fludarabine phosphate 74 Filgrastim 72 Lenalidomide 59 Radiotherapy 52 Mycophenolic Acid 52 Cytarabine 50 Melphalan 47 Cyclosporine 46 Whole-Body Irradiation 43 Busulfan 43 Carmustine 40 Tacrolimus 36 Methotrexate 36 Antilymphocyte Serum 33 Gemcitabine 31 fludarabine 29 Ifosfamide 27 Carboplatin 27 Dexamethasone 26 Granulocyte Colony-Stimulating Factor 25 Methylprednisolone 24 Magnetic Resonance Spectroscopy 24 polatuzumab vedotin 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03201471 2018-08-02

DLBCL

First Affiliated Hospital of Zhejiang University

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡